Riverain’s imaging software cleared by FDA
The FDA has granted 510(k) clearance to Riverain Technologies’ ClearRead +Confirm software that improves the clarity of chest X-rays and reduces the time it takes radiologists to confirm the proper placement of tubes, lines and cardiac wires in the chest.
ClearRead +Confirm software received CE Mark approval in Europe last November.
ClearRead +Confirm increases portable chest X-ray readability by selectively increasing contrast and suppressing the clavicles and ribs in the image, thus removing obstacles that could obscure visibility of various tubes, lines and cardiac wires.
“ClearRead +Confirm gives radiologists a clearer view of portable chest X-ray images at a critical point in patient care, when treatment decisions depend on the confirmation of proper tube and line placement,” said Riverain’s CEO Steve Worrell. “The software saves time without sacrificing precision, benefitting physicians and patients alike.”